A Shigella Vaccine Against Prevalent Serotypes
This article, published in Clinical Infectious Diseases, discusses the case for development of a pediatric vaccine against Shigella, which is a leading cause of diarrheal disease among children aged 12 to 59 months. The authors provide an analysis of previous studies on Shigella vaccine candidates, which demonstrates the progress made thus far and highlights the complications associated with developing a Shigella vaccine.
Author: Van de Verg LL, Venkatesan MM
» Visit web page (English)
(Located at cid.oxfordjournals.org)
Citation: Van de Verg LL, Venkatesan MM. A Shigella Vaccine Against Prevalent Serotypes. Clinical Infectious Disease. 2014;Early Online Publication.
Resource types: Peer-reviewed journal
Diseases/vaccines: Shigellosis and enterotoxigenic Escherichia coli (ETEC)